News & Updates

Ertugliflozin improves glycaemic outcomes in patients with stage 3 CKD

21 Jul 2021 by

Ertugliflozin significantly improves glycaemic outcomes in patients with type 2 diabetes (T2D) who have stage 3 chronic kidney disease (CKD), according to a subgroup analysis of the VERTIS CV* trial presented at ADA 2021.

Ertugliflozin improves glycaemic outcomes in patients with stage 3 CKD

21 Jul 2021

Walking downhill can lower BMI, improve glucose tolerance

20 Jul 2021

Eccentric exercises like downhill hiking seem to be effective at reducing body mass index (BMI) and inflammation, as well as pose benefits for glucose tolerance, a recent study has found.

Walking downhill can lower BMI, improve glucose tolerance

20 Jul 2021

Dorzagliatin a new hope for T2D

19 Jul 2021 by

In drug-naïve Chinese patients with type 2 diabetes (T2D), treatment with the first-in-class, glucose sensitizer dorzagliatin led to sustained glycaemic control, according to updated findings from the 52-week phase III SEED* study presented at ADA 2021.

Dorzagliatin a new hope for T2D

19 Jul 2021

Social isolation during COVID-19 impacts comorbidities, mental health

16 Jul 2021 by

Isolation during the COVID-19 pandemic may lead to deterioration in comorbidities and mental health, according to two studies presented at the European Society of Endocrinology virtual conference (e-ECE 2021).

Social isolation during COVID-19 impacts comorbidities, mental health

16 Jul 2021

Insulin glargine/lixisenatide combo drug trumps biphasic insulin in poorly controlled T2D

16 Jul 2021 by

Once-daily iGlarLixi is superior to twice-daily premixed biphasic insulin aspart 30 (BIAsp 30) in glycaemic control and reducing body weight, along with less risk of hypoglycaemia, in patients with suboptimally controlled type 2 diabetes (T2D) despite treatment with basal insulin plus oral antihyperglycaemic drugs (OADs), according to the SoliMix trial presented at ADA 2021.

Insulin glargine/lixisenatide combo drug trumps biphasic insulin in poorly controlled T2D

16 Jul 2021

Vitamin D helps fight colorectal cancer, precursor lesions in young women

16 Jul 2021

Increased intake of vitamin D appears to reduce the risk of developing early-onset colorectal cancer and its precursor lesions in young women, as suggested in a study.

Vitamin D helps fight colorectal cancer, precursor lesions in young women

16 Jul 2021

Intermittent very-low calorie diet helps with glycaemic control

15 Jul 2021

Intermittent very-low calorie diet appears to be effective in reaching optimal glycaemic control in obese type 2 diabetes patients, regardless of timing, a recent study has found.

Intermittent very-low calorie diet helps with glycaemic control

15 Jul 2021

Original New Drug Application Approvals by US FDA (01 - 15 July 2021)

15 Jul 2021

New drug applications approved by US FDA as of 01-15 July 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01 - 15 July 2021)

15 Jul 2021

Polypharmacy up, potentially inappropriate medication down in older diabetic patients

15 Jul 2021 by

An increasing trend in polypharmacy has been observed in both older and middle-aged people with diabetes, particularly in patients between 55 and 64 years of age, according to a study. However, a decrease in potentially inappropriate medication (PIM) is seen in older patients with polypharmacy.

Polypharmacy up, potentially inappropriate medication down in older diabetic patients

15 Jul 2021

Laparoscopic sleeve gastrectomy elevates sulfated bile acid levels in obese Asians

14 Jul 2021 by

Serum concentrations of sulfated bile acids (BAs) are significantly increased in morbidly obese Asians 6 months after laparoscopic sleeve gastrectomy (LSG), which may then contribute to the recovery of metabolic health in this population, a Singapore study has shown.

Laparoscopic sleeve gastrectomy elevates sulfated bile acid levels in obese Asians

14 Jul 2021

News & Updates

Filter by Specialty:

Specialty:

Ertugliflozin improves glycaemic outcomes in patients with stage 3 CKD

Ertugliflozin improves glycaemic outcomes in patients with stage 3 CKD

Walking downhill can lower BMI, improve glucose tolerance

Walking downhill can lower BMI, improve glucose tolerance

Dorzagliatin a new hope for T2D

Dorzagliatin a new hope for T2D

Social isolation during COVID-19 impacts comorbidities, mental health

Social isolation during COVID-19 impacts comorbidities, mental health

Insulin glargine/lixisenatide combo drug trumps biphasic insulin in poorly controlled T2D

Insulin glargine/lixisenatide combo drug trumps biphasic insulin in poorly controlled T2D

Vitamin D helps fight colorectal cancer, precursor lesions in young women

Vitamin D helps fight colorectal cancer, precursor lesions in young women

Intermittent very-low calorie diet helps with glycaemic control

Intermittent very-low calorie diet helps with glycaemic control

Original New Drug Application Approvals by US FDA (01 - 15 July 2021)

Original New Drug Application Approvals by US FDA (01 - 15 July 2021)

Polypharmacy up, potentially inappropriate medication down in older diabetic patients

Polypharmacy up, potentially inappropriate medication down in older diabetic patients

Laparoscopic sleeve gastrectomy elevates sulfated bile acid levels in obese Asians

Laparoscopic sleeve gastrectomy elevates sulfated bile acid levels in obese Asians